Loading
Latest filing published 26 Jul 2023 for GreenLight Biosciences Holdings, PBC, €30k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Martha Schlicher (board member) discloses dealings in GreenLight Biosciences Holdings, PBC to SEC (Form 4). We count 2 filings; the first trade dates from 2 February 2022 and the latest from 24 July 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 26 July 2023 came the latest disclosure, a transaction for €30k in GreenLight Biosciences Holdings, PBC. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations